C
TNGX icon

Covestor’s Tango Therapeutics TNGX Stock Holding History

Covestor’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
36
+26
+260% +$643 ﹤0.01% 2348
2026
Q1 		$0 Sell
10
-22
-69% -$306 ﹤0.01% 2768
2025
Q4 		$0 Hold
32
– – ﹤0.01% 2739
2025
Q3 		$0 Hold
32
– – ﹤0.01% 2774
2025
Q2 		$0 Sell
32
-2
-6% -$5 ﹤0.01% 2757
2025
Q1 		$0 Buy
34
+24
+240% +$59 ﹤0.01% 2730
2024
Q4 		$0 Buy
10
+1
+11% +$5 ﹤0.01% 2742
2024
Q3 		$0 Sell
9
-1
-10% -$10 ﹤0.01% 2769
2024
Q2 		$0 Hold
10
– – ﹤0.01% 2760
2024
Q1 		$0 Sell
10
-4
-29% -$43 ﹤0.01% 2741
2023
Q4 		$0 Buy
+14
New +$122 ﹤0.01% 2716

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Covestor's TNGX Position: Q2 2026 in Review

Covestor increased its Tango Therapeutics (TNGX) stake by 260% in Q2 2026, buying an estimated $643 and bringing the position to 36 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2348.

Covestor first reported a position in TNGX in Q4 2023 and has held it in 11 quarters since. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Covestor held 36 shares of Tango Therapeutics worth $1K as of Q2 2026.
  • Covestor bought 26 Tango Therapeutics shares in Q2 2026, an estimated $643.
  • Tango Therapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2348 holding.
  • Covestor first reported a position in Tango Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.